These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9497326)
1. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326 [TBL] [Abstract][Full Text] [Related]
2. Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. Garner B; Witting PK; Waldeck AR; Christison JK; Raftery M; Stocker R J Biol Chem; 1998 Mar; 273(11):6080-7. PubMed ID: 9497325 [TBL] [Abstract][Full Text] [Related]
3. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII. Lagrost L; Perségol L; Lallemant C; Gambert P J Biol Chem; 1994 Feb; 269(5):3189-97. PubMed ID: 8106353 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525 [TBL] [Abstract][Full Text] [Related]
5. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. Wang WQ; Merriam DL; Moses AS; Francis GA J Biol Chem; 1998 Jul; 273(28):17391-8. PubMed ID: 9651324 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake. Pilon A; Briand O; Lestavel S; Copin C; Majd Z; Fruchart JC; Castro G; Clavey V Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1074-81. PubMed ID: 10764676 [TBL] [Abstract][Full Text] [Related]
7. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387 [TBL] [Abstract][Full Text] [Related]
9. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis. Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol mobilization by free and lipid-bound apoAI(Milano) and apoAI(Milano)-apoAII heterodimers. Wang WQ; Moses AS; Francis GA Biochemistry; 2001 Mar; 40(12):3666-73. PubMed ID: 11297434 [TBL] [Abstract][Full Text] [Related]
11. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161 [TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages. Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906 [TBL] [Abstract][Full Text] [Related]
13. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice. Holvoet P; Danloy S; Collen D Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000 [TBL] [Abstract][Full Text] [Related]
14. Determination of myeloperoxidase-induced apoAI-apoAII heterodimers in high-density lipoprotein. Kameda T; Usami Y; Shimada S; Haraguchi G; Matsuda K; Sugano M; Kurihara Y; Isobe M; Tozuka M Ann Clin Lab Sci; 2012; 42(4):384-91. PubMed ID: 23090734 [TBL] [Abstract][Full Text] [Related]
16. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma. Nichols AV; Blanche PJ; Shore VG; Gong EL Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827 [TBL] [Abstract][Full Text] [Related]
17. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice. Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644 [TBL] [Abstract][Full Text] [Related]
18. Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Tanaka Y; Ando Y; Kumamoto T; Miyazaki A; Nakamura M; Nakayama M; Araki S; Ando M Biochim Biophys Acta; 1994 Feb; 1225(3):311-6. PubMed ID: 8312379 [TBL] [Abstract][Full Text] [Related]
19. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein. Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365 [TBL] [Abstract][Full Text] [Related]
20. Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study. Wilkins JT; Seckler HS; Rink J; Compton PD; Fornelli L; Thaxton CS; LeDuc R; Jacobs D; Doubleday PF; Sniderman A; Lloyd-Jones DM; Kelleher NL J Am Heart Assoc; 2021 Sep; 10(17):e019890. PubMed ID: 34472376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]